STUDY TITLE: BONE METASTASES FROM PROSTATE CANCER EXPERIMENTAL MODEL



Similar documents
.org. Metastatic Bone Disease. Description

Targeting Specific Cell Signaling Pathways for the Treatment of Malignant Peritoneal Mesothelioma

Pathophysiology of bone metastasis : how does it apply to pain treatment in palliative care? JP Vuillez, Grenoble, France

CHARACTERSTIC RADIOGRAPHIC APPEARANCE

The Effect of Myeloma Cells on Bone Metabolism is Heterogenous and Correlates with Underlying Genetic Lesions and Bone Disease In Vivo

OPG-Fc inhibits ovariectomy-induced growth of disseminated breast cancer cells in bone.

A PATIENT S GUIDE TO ABLATION THERAPY

Radiopharmaceuticals that can be used for alleviating pain caused by bone metastases:

Nuevas tecnologías basadas en biomarcadores para oncología

Introduction. Case History

OBJECTIVES By the end of this segment, the community participant will be able to:

A Diagnostic Chest XRay: Multiple Myeloma

Unwrapping 3D microct images of bone to planar projection images for quantifying cortical osteolysis in myeloma

Metastatic Bone Disease and Multiple Myeloma

Clinical Laboratory Parameters For Crl:WI(Han)Rats

CONTRACTING ORGANIZATION: University of Alabama at Birmingham Birmingham, AL 35294

2015 HCPCS CODE ADDITIONS

Newsletter. WntResearch AB, Medeon Science Park, Per Albin Hanssons väg 41, Malmö, Sweden. Primary Objective:

The Diagnosis of Cancer in the Pathology Laboratory

General Rules SEER Summary Stage Objectives. What is Staging? 5/8/2014

Metastasis. brain metastasis from bronchial carcinoma

Disease/Illness GUIDE TO ASBESTOS LUNG CANCER. What Is Asbestos Lung Cancer? Telephone

Linfoma maligno pulmonar tratado com Nerium oleander. CASE REPORT

Effects of Two Proprietary Compounds in Multiple Sclerosis DATE

KIDNEY FUNCTION RELATION TO SIZE OF THE TUMOR IN RENAL CELL CANCINOMA

How Does a Doctor Test for AIDS?

PSA Testing 101. Stanley H. Weiss, MD. Professor, UMDNJ-New Jersey Medical School. Director & PI, Essex County Cancer Coalition. weiss@umdnj.

Tissue Cross-Reactivity of QRX-111 with Human, Cynomolgus Monkey and Rat Tissues in Vitro

Title: Immunohistochemical staining of radixin and moesin in prostatic adenocarcinoma

Critical Illness Products in South Africa

9. Discuss guidelines for follow-up post-thyroidectomy for cancer (labs/tests) HH

Rotation Specific Goals & Objectives: University Health Network-Princess Margaret Hospital/ Sunnybrook Breast/Melanoma

A912: Kidney, Renal cell carcinoma

Summer Application Instructions

Oklahoma Facts CPT. Definitions. Mohs Micrographic Surgery. What Does That Mean? Billing and Coding for Mohs Surgery

Baylor Radiosurgery Center

Radiologic Diagnosis of Spinal Metastases

PCA3 DETECTION TEST FOR PROSTATE CANCER DO YOU KNOW YOUR RISK OF HAVING CANCER?

CA 125 definitions agreed by GCIG November 2005

CHAPTER 2. Neoplasms (C00-D49) March MVP Health Care, Inc.

EDUCATION TEACHING ACTIVITIES. DEVELOPMENT and ASSESSMENT

WHICH SAMPLES SHOULD BE SUBMITTED WHEN LYMPHOID NEOPLASIA IS SUSPECTED?

COLONIAL LIFE & ACCIDENT INSURANCE COMPANY P.O. Box 1365, Columbia, South Carolina

COLONIAL LIFE & ACCIDENT INSURANCE COMPANY 1200 Colonial Life Boulevard, P. O. Box 1365 Columbia, South Carolina (800)

Comparison between photoacoustic mammography images of breasts cancers and histological staining patterns of CD31 and carbonic anhydrase IX

Case of the. Month October, 2012

Kidney Cancer OVERVIEW

Clinical Laboratory Parameters for Crl:CD(SD) Rats. March, Information Prepared by Mary L.A. Giknis, Ph.D. Charles B. Clifford, D.V.M., Ph.D.

GM23226*A. Certificate of Analysis

LIVER TUMORS PROFF. S.FLORET

MANAGEMENT OF BENIGN BONE TUMORS

BRAIN & BEHAVIOR LAB PSY 4515 S P R I N G

GUIDELINES FOR THE MANAGEMENT OF LUNG CANCER


Experience of a Pediatric Oncology Clinical Research Center in Brazil. Antonio Sergio Petrilli, MD, PhD

Saturation Biopsy vs. 3D Spatial Biopsy vs. Free Hand Ultrasound biopsy for Targeted Prostate Cancer Therapies

Prostate Cancer. Treatments as unique as you are

Stereotactic Radiotherapy for Prostate Cancer using CyberKnife

P4 Distribution of Cetuximab in Models of Human Lung Cancer

Patient Prep Information

R E X C A N C E R C E N T E R. Annual Report Rex Cancer Care Committee 2012 On behalf of the Rex Cancer Center & Rex Health Care

Treating Thyroid Cancer using I-131 Maximum Tolerable Dose Method

What You Need to Know for Better Bone Health

Your partner in immunology

Principal Investigator: Valerie W. Rusch, MD, FACS, Chief, Thoracic Surgery Memorial Sloan-Kettering Cancer Center

Coding Dermatology Procedures. Presented by: Betty A Hovey Director, ICD-10 Development and Training AAPC

EVALUATION OF THE EFFECT OF THE COMPOUND RIBOXYL ON THE ATP LEVEL AND CELLULAR RESPIRATION FROM HUMAN DERMAL FIBROBLASTS

Resorptive Changes of Maxillary and Mandibular Bone Structures in Removable Denture Wearers

Us TOO University Presents: Understanding Diagnostic Testing

Detection and staging of recurrent prostate cancer is still one of the important clinical problems in prostate cancer. A rise in PSA or biochemical

Cryosurgery in Cancer Treatment: Questions and Answers. Key Points

A 70-year old Man with Pleural Effusion

Histologic comparison of biologic width around teeth versus implants: The effect on bone preservation

Recommendations for cross-sectional imaging in cancer management, Second edition

why? 75 percent The percentage of healthy individuals over age 40 who will become critically ill at some time in the future. 3

HOW TO FILE ACCIDENT AFLAC CLAIM

IKDT Laboratory. IKDT as Service Lab (CRO) for Molecular Diagnostics

What is Cancer? Cancer is a genetic disease: Cancer typically involves a change in gene expression/function:

H. Richard Alexander, Jr., M.D. Department of Surgery and The Greenebaum Cancer Center University of Maryland School of Medicine Baltimore, Md

SUNY DOWNSTATE MEDICAL CENTER SURGERY GRAND ROUNDS February 28, 2013 VERENA LIU, MD ROSEANNA LEE, MD

Reconsideration Code Reconsideration Code Description Nuclear Matrix Protein 22 (NMP22), qualitative

METHODS OF VITAMIN ANALYSIS

COMMITTEE FOR PROPRIETARY MEDICINAL PRODUCTS (CPMP) NOTE FOR GUIDANCE ON THE PRE-CLINICAL EVALUATION OF ANTICANCER MEDICINAL PRODUCTS

Evaluation of Diagnostic Tests

CHS BONES AND SKELETAL TISSUES

SPECT and PET imaging in porcine inflammation and infection models. UCPH pig model network seminar

The Facts on Equine Drug Testing

Curriculum Vitæ PROFESSIONAL RECORD

Transcription:

STUDY TITLE: BONE METASTASES FROM PROSTATE CANCER EXPERIMENTAL MODEL Updated 2011/01/11

Protocol study Animals: Age: Sex: Strain: Supplier: Rats 5 weeks old (upon delivery) Male Sprague Dawley Charles River Laboratories or Elevage Janvier

Experimental model Induction of the pathology: Injection of rat prostatic carcinoma cells (AT6-1 cells) in the medullar cavity of long bones (femora right) Arthrotomy Preparation of the medullar cavity Injection intra-osseous of AT6-1 cells

Experimental model Development of the pathology: The tumor is detectable 3 weeks after the cell injection (by radiography) The tumor development is mainly intra-osseous, and, some times para-osseous by the invasion of the neighbouring muscular tissues Similar lesions to cells observed in the human prostatic carcinoma pathology Osteolytic and osteoblastic lesions CT AT6-1 cells CT AT6-1 cells

Treatment Any administration route Treatment can be defined in accordance with the sponsor (start and frequency)

Clinical follow-up Weight evolution General clinical state Detailed clinical examinations Reactions after surgery and reaction to compound administration Tumor volume measurement (in case of para-osseous development)

Biological follow-up Dosage of serum samples by immunoenzymatic method (ELISA) in 96-well plates in duplicate Serum markers of bone resorption : CTX, TRAP 5b, Serum markers of bone formation : PAL, Osteocalcin,

Kinetic of radiographical analyses Radiological follow-up Scoring of radiographs: Scoring Degree of bone deformity 0 No bone metastases 1 Slight bone metastases 2 Medium bone metastases 3 High bone metastases 4 Strong bone metastases Bone metastases induced femur deformation(yellow arrow)

Microscanner analysis Qualitative and quantitative analysis by microtomography (Skyscan 1076) 3 dimension analysisof the sample Study of the trabecular architecture Non destructive technique (sample usable for other tests) AT6-1 cells Control

Histological study Animals euthanasia at the end of the study Histological studies performed on left posterior legs (femora) of each animal Per rat: Femora are embedded in paraffin after decalcification or in resin Stainings proposed: -Von Kossastaining / RESIN - Goldner s Trichrome staining / Staining -TRAP staining / PARAFFIN - Masson s Trichrome staining/ PARAFFIN - Hematoxilin/ Eosin / PARAFFIN Other stainings are available

SYNOPSIS Clinical follow-up twice a week Cell injection Treatment Euthanasia Delivery of animals J23 J30 J37 J44 Time (days) J-14 Quarantine J-7 J0 J7 J14 J21 J28 J35 J42 J49 Histological analysis Radiography ELISA assays Blood sampling

Ronan LE BOT CEO ronan.lebot@atlantic-bone-screen.com Florence DAUBINE, PhD Project Manager florence.daubine@atlantic-bone-screen.com Contact us Fabien PETIT Project Manager fabien.petit@atlantic-bone-screen.com Elisabeth PORCHER Business Development Manager elisabeth.porcher@atlantic-bone-screen.com ATLANTIC BONE SCREEN SAS 1, rue Gaston Veil 44000 Nantes France www.atlantic-bone-screen.com Tel : +33(0)2 40 41 11 25 Fax : + 33(0)2 40 41 28 35 And we will send you a tailor-made protocol study